This inventor holds 1 USPTO granted patent. Top assignees: Astrazeneca Ab, Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2012.
Company Filing History:
1 out of 1,528 
1 out of 140 Years Active: 2012
Title: The Innovative Contributions of Tom McInally
Introduction
Tom McInally is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on 8-oxoadenine derivatives. His research focuses on the modulation of Toll-like Receptor 7 (TLR7), which has implications for various therapeutic applications.
Latest Patents
Tom McInally holds a patent for "8-oxoadenine derivatives acting as modulators of TLR7." This invention provides a range of 8-oxoadenine derivatives, processes for their preparation, and pharmaceutical compositions containing them. These derivatives are particularly valuable in the treatment of asthma, hepatitis, allergic diseases, viral and bacterial infections, as well as cancer.
Career Highlights
Throughout his career, Tom has worked with prominent companies in the pharmaceutical industry, including Dainippon Sumitomo Pharma Co., Ltd. and AstraZeneca. His experience in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic solutions.
Collaborations
Tom has collaborated with esteemed colleagues such as Stephen Thom and Hiroki Wada. These partnerships have further enriched his research and innovation efforts in the pharmaceutical field.
Conclusion
Tom McInally's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions, particularly in the area of TLR7 modulation, hold promise for advancing therapeutic options for various diseases.